Agnc Investment Corp
Change company Symbol lookup
Select an option...
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc
FONR Fonar Corp
WBRRFX BlackRock Russell 2000 Growth Index Fund
WSM Williams-Sonoma Inc
BLK BlackRock Inc
TSEM Tower Semiconductor Ltd

Company profile

AGNC Investment Corp., formerly American Capital Agency Corp., is a real estate investment trust. The Company invests in agency residential mortgage-backed securities on a leveraged basis. Its investments consist of residential mortgage pass-through securities and collateralized mortgage obligations (CMOs) for which the principal and interest payments are guaranteed by a government-sponsored enterprise, such as the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac), or by the United States Government agency, such as the Government National Mortgage Association (Ginnie Mae) (collectively, GSEs). Its agency securities include agency residential mortgage-backed securities (Agency RMBS) and to-be-announced forward contracts (TBAs). Its Non-Agency Securities include credit risk transfer securities (CRT), non-agency residential mortgage-backed securities (Non-Agency RMBS) and commercial mortgage-backed securities (CMBS).

Closing Price
Day's Change
-0.08 (-0.57%)
B/A Size
Day's High
Day's Low

10-day average volume:

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds STAAR Surgical (STAA) Investors of Securities Fraud Class Action and Encourages Investors with Losses to Contact the Firm Now

5:46 pm ET September 24, 2020 (Globe Newswire) Print

Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been filed and certain investors may have valuable claims.

Class Period: Feb. 26, 2020 - Aug. 10, 2020

Lead Plaintiff Deadline: Oct. 19, 2020


Contact An Attorney Now:


STAAR Surgical Company (STAA) Securities Class Action:

According to the complaint, STAAR and senior management repeatedly overstated and/or mischaracterized (1) the company's sales and growth in China, (2) its marketing spend, and (3) its research and development expenditures.

Investors began to learn the truth, according to the complaint, after the markets closed on Aug. 5, 2020, when STAAR reported disappointing Q2 2020 sales and a net loss versus net income for the prior year second quarter. In addition, the company revealed its massive- and growing- exposure to a single distributor in China who accounted for 53% of Q2 2020 net sales versus 49% for the year-earlier quarter, and who accounted for 57% of trade receivables versus 43% for Q1 2020.

Then, on Aug. 11, 2020, research firm J Capital published a scathing report calling STAAR's China success story into serious question. More specifically, J Capital accused the company of overstating its sales in China by at least one-third (or $21.6 mln), "meaning all of the company's $14 mln in 2019 profit is fake." The report - based on over 75 interviews with former employees, site visits to China and Switzerland, and extensive review of public documents - concludes STAAR reports fake sales revenues by overstating sales and then marking up actual marketing costs to hide "phantom" revenue. J Capital also found STAAR's largest China client bought only about half the lenses STAAR reported.

These events caused the price of STAAR shares to sharply decline.

"We're focused on investors' losses and proving STAAR cooked its books by inflating its China sales," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are a STAAR investor, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding STAAR should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email

About Hagens Berman

Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.


Reed Kathrein, 844-916-0895

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.